Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Teladoc Health, Inc.TDOC · Entity 1547 | CHIEF PEOPLE OFFICER | August 30, 2024 | September 04, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Teladoc Health, Inc.
Report date August 30, 2024 · Filed September 04, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 44,914 |
Ending reported balance
After 2024-09-03 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2024-08-30 · Exercise / conversion · Acquired 977 · Balance 42,663 F1: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Row 2 · 2024-08-30 · Exercise / conversion · Acquired 1,179 · Balance 43,842 F2: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Row 3 · 2024-08-30 · Exercise / conversion · Acquired 2,867 · Balance 46,709 F2: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Row 4 · 2024-09-03 · Sale · Disposed 1,795 · Balance 44,914 F3: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. |
| Performance Stock UnitsSEC Table II · derivative / convertible security | Direct | 5,865 |
Reported balance
After 2024-08-30 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2024-08-30 · Exercise / conversion · Disposed 977 · Balance 5,865 F1: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F4: The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 2,359 |
Reported balance
After 2024-08-30 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2024-08-30 · Exercise / conversion · Disposed 1,179 · Balance 2,359 F2: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F5: On March 1, 2022, the reporting person was granted 14,149 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 17,208 |
Reported balance
After 2024-08-30 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2024-08-30 · Exercise / conversion · Disposed 2,867 · Balance 17,208 F2: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F6: On March 3, 2023, the reporting person was granted 34,412 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
F2: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F3: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
F4: The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F5: On March 1, 2022, the reporting person was granted 14,149 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F6: On March 3, 2023, the reporting person was granted 34,412 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 27, 2023 Filed Feb 28, 2023 22:57 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 1,090 | $26.69 | $29,088.83 |
DisclosureSEC source: 0001415889-23-003534 · form4-02282023_100210.xml · nonDerivative · entry 1 Geshuri Arnnon · CIK 0001830520 · CHIEF PEOPLE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,227 F1 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. Read SEC document |
| February 03, 2023 Filed Feb 7, 2023 21:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 750 | $0.00 Strike: $2.73 | $0.00 |
DisclosureSEC source: 0001415889-23-002073 · form4-02072023_090244.xml · derivative · entry 6 Geshuri Arnnon · CIK 0001830520 · CHIEF PEOPLE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 231,528 Underlying: Common Stock · 750 shares Expires 2027-12-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on November 29, 2022. F2 · derivative.exercise_date: One-fourth of the option vested on December 4, 2018 and 1/48 of the option vests monthly thereafter. Read SEC document |
| February 03, 2023 Filed Feb 7, 2023 21:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 750 | $0.00 Strike: $2.73 | $0.00 |
DisclosureSEC source: 0001415889-23-002073 · form4-02072023_090244.xml · derivative · entry 5 Geshuri Arnnon · CIK 0001830520 · CHIEF PEOPLE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 232,278 Underlying: Common Stock · 750 shares Expires 2027-12-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on November 29, 2022. F2 · derivative.exercise_date: One-fourth of the option vested on December 4, 2018 and 1/48 of the option vests monthly thereafter. Read SEC document |
| February 03, 2023 Filed Feb 7, 2023 21:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 750 | $32.00 | $24,000.00 |
DisclosureSEC source: 0001415889-23-002073 · form4-02072023_090244.xml · nonDerivative · entry 4 Geshuri Arnnon · CIK 0001830520 · CHIEF PEOPLE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,317 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on November 29, 2022. Read SEC document |
| February 03, 2023 Filed Feb 7, 2023 21:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 750 | $2.73 | $2,047.50 |
DisclosureSEC source: 0001415889-23-002073 · form4-02072023_090244.xml · nonDerivative · entry 3 Geshuri Arnnon · CIK 0001830520 · CHIEF PEOPLE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,067 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on November 29, 2022. Read SEC document |
| February 03, 2023 Filed Feb 7, 2023 21:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 750 | $31.63 | $23,722.50 |
DisclosureSEC source: 0001415889-23-002073 · form4-02072023_090244.xml · nonDerivative · entry 2 Geshuri Arnnon · CIK 0001830520 · CHIEF PEOPLE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,317 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on November 29, 2022. Read SEC document |
| February 03, 2023 Filed Feb 7, 2023 21:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 750 | $2.73 | $2,047.50 |
DisclosureSEC source: 0001415889-23-002073 · form4-02072023_090244.xml · nonDerivative · entry 1 Geshuri Arnnon · CIK 0001830520 · CHIEF PEOPLE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,067 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on November 29, 2022. Read SEC document |
| February 02, 2023 Filed Feb 3, 2023 21:08 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 750 | $0.00 Strike: $2.73 | $0.00 |
DisclosureSEC source: 0001415889-23-001922 · form4-02032023_090205.xml · derivative · entry 6 Geshuri Arnnon · CIK 0001830520 · CHIEF PEOPLE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 233,028 Underlying: Common Stock · 750 shares Expires 2027-12-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on November 29, 2022. F2 · derivative.exercise_date: One-fourth of the option vested on December 4, 2018 and 1/48 of the option vests monthly thereafter. Read SEC document |
| February 02, 2023 Filed Feb 3, 2023 21:08 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 750 | $0.00 Strike: $2.73 | $0.00 |
DisclosureSEC source: 0001415889-23-001922 · form4-02032023_090205.xml · derivative · entry 5 Geshuri Arnnon · CIK 0001830520 · CHIEF PEOPLE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 233,778 Underlying: Common Stock · 750 shares Expires 2027-12-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on November 29, 2022. F2 · derivative.exercise_date: One-fourth of the option vested on December 4, 2018 and 1/48 of the option vests monthly thereafter. Read SEC document |
| February 02, 2023 Filed Feb 3, 2023 21:08 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 750 | $32.42 | $24,315.00 |
DisclosureSEC source: 0001415889-23-001922 · form4-02032023_090205.xml · nonDerivative · entry 4 Geshuri Arnnon · CIK 0001830520 · CHIEF PEOPLE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,317 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on November 29, 2022. Read SEC document |
| February 02, 2023 Filed Feb 3, 2023 21:08 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 750 | $2.73 | $2,047.50 |
DisclosureSEC source: 0001415889-23-001922 · form4-02032023_090205.xml · nonDerivative · entry 3 Geshuri Arnnon · CIK 0001830520 · CHIEF PEOPLE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,067 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on November 29, 2022. Read SEC document |
| February 02, 2023 Filed Feb 3, 2023 21:08 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 750 | $34.00 | $25,500.00 |
DisclosureSEC source: 0001415889-23-001922 · form4-02032023_090205.xml · nonDerivative · entry 2 Geshuri Arnnon · CIK 0001830520 · CHIEF PEOPLE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,317 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on November 29, 2022. Read SEC document |
| February 02, 2023 Filed Feb 3, 2023 21:08 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 750 | $2.73 | $2,047.50 |
DisclosureSEC source: 0001415889-23-001922 · form4-02032023_090205.xml · nonDerivative · entry 1 Geshuri Arnnon · CIK 0001830520 · CHIEF PEOPLE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,067 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on November 29, 2022. Read SEC document |
| February 01, 2023 Filed Feb 2, 2023 21:22 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 750 | $0.00 Strike: $2.73 | $0.00 |
DisclosureSEC source: 0001415889-23-001802 · form4-02022023_090256.xml · derivative · entry 3 Geshuri Arnnon · CIK 0001830520 · CHIEF PEOPLE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 234,528 Underlying: Common Stock · 750 shares Expires 2027-12-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on November 29, 2022. F2 · derivative.exercise_date: One-fourth of the option vested on December 4, 2018 and 1/48 of the option vests monthly thereafter. Read SEC document |
| February 01, 2023 Filed Feb 2, 2023 21:22 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 750 | $30.00 | $22,500.00 |
DisclosureSEC source: 0001415889-23-001802 · form4-02022023_090256.xml · nonDerivative · entry 2 Geshuri Arnnon · CIK 0001830520 · CHIEF PEOPLE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,317 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on November 29, 2022. Read SEC document |
| February 01, 2023 Filed Feb 2, 2023 21:22 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 750 | $2.73 | $2,047.50 |
DisclosureSEC source: 0001415889-23-001802 · form4-02022023_090256.xml · nonDerivative · entry 1 Geshuri Arnnon · CIK 0001830520 · CHIEF PEOPLE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,067 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on November 29, 2022. Read SEC document |
| November 28, 2022 Filed Nov 29, 2022 21:16 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 2,398 | $27.35 | $65,594.89 |
DisclosureSEC source: 0001415889-22-011819 · form4-11292022_091144.xml · nonDerivative · entry 1 Geshuri Arnnon · CIK 0001830520 · CHIEF PEOPLE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,317 F1 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. Read SEC document |
| October 31, 2022 Filed Nov 1, 2022 20:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 527 | $29.56 | $15,575.49 |
DisclosureSEC source: 0001415889-22-010933 · form4-11012022_011100.xml · nonDerivative · entry 2 Geshuri Arnnon · CIK 0001830520 · CHIEF PEOPLE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,715 F2 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit award. Read SEC document |
| October 28, 2022 Filed Nov 1, 2022 20:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 1,060 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-010933 · form4-11012022_011100.xml · derivative · entry 3 Geshuri Arnnon · CIK 0001830520 · CHIEF PEOPLE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,061 Underlying: Common Stock · 1,060 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F3 · derivative.exercise_date: On October 30, 2020, the reporting person was granted 3,181 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. F3 · derivative.expiration_date: On October 30, 2020, the reporting person was granted 3,181 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| October 28, 2022 Filed Nov 1, 2022 20:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,060 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-22-010933 · form4-11012022_011100.xml · nonDerivative · entry 1 Geshuri Arnnon · CIK 0001830520 · CHIEF PEOPLE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,242 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| August 26, 2022 Filed Aug 29, 2022 20:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 4,098 | $34.27 | $140,450.75 |
DisclosureSEC source: 0001415889-22-009138 · form4-08292022_010804.xml · nonDerivative · entry 1 Geshuri Arnnon · CIK 0001830520 · CHIEF PEOPLE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,182 F1 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 20:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantEmployee Stock Option (right to buy) · Derivative | 49,377 | $0.00 Strike: $32.62 | $0.00 |
DisclosureSEC source: 0001415889-22-006083 · form4-06032022_010616.xml · derivative · entry 1 Geshuri Arnnon · CIK 0001830520 · CHIEF PEOPLE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,377 Underlying: Common Stock · 49,377 shares Expires 2032-05-31 F1 · derivative.exercise_date: The option will vest as to one-third of the shares on June 1, 2023. The remainder of the shares will vest in 24 substantially equal monthly installments thereafter. Read SEC document |
| May 26, 2022 Filed May 31, 2022 20:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 2,888 | $31.86 | $92,011.68 |
DisclosureSEC source: 0001415889-22-005891 · form4-05312022_010532.xml · nonDerivative · entry 1 Geshuri Arnnon · CIK 0001830520 · CHIEF PEOPLE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,280 F1 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 21:18 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 14,149 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-001903 · edgar.xml · derivative · entry 2 Geshuri Arnnon · CIK 0001830520 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,149 Underlying: Common Stock · 14,149 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F3 · derivative.exercise_date: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F3 · derivative.expiration_date: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| February 28, 2022 Filed Mar 2, 2022 21:18 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 2,613 | $78.14 | $204,190.27 |
DisclosureSEC source: 0001179110-22-001903 · edgar.xml · nonDerivative · entry 1 Geshuri Arnnon · CIK 0001830520 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,168 F1 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. Read SEC document |
| November 26, 2021 Filed Nov 29, 2021 21:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 3,664 | $116.08 | $425,317.12 |
DisclosureSEC source: 0001179110-21-010439 · edgar.xml · nonDerivative · entry 1 Geshuri Arnnon · CIK 0001830520 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,781 F1 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. Read SEC document |
| November 01, 2021 Filed Nov 2, 2021 20:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 523 | $150.66 | $78,794.13 |
DisclosureSEC source: 0001179110-21-009755 · edgar.xml · nonDerivative · entry 2 Geshuri Arnnon · CIK 0001830520 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,445 F3 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit award. Read SEC document |
| October 29, 2021 Filed Nov 2, 2021 20:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 1,060 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-009755 · edgar.xml · derivative · entry 3 Geshuri Arnnon · CIK 0001830520 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,121 Underlying: Common Stock · 1,060 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F2 · derivative.exercise_date: On October 30, 2020, the reporting person was granted 3,181 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. F2 · derivative.expiration_date: On October 30, 2020, the reporting person was granted 3,181 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| October 29, 2021 Filed Nov 2, 2021 20:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,060 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-21-009755 · edgar.xml · nonDerivative · entry 1 Geshuri Arnnon · CIK 0001830520 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,968 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| August 26, 2021 Filed Aug 27, 2021 20:13 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 4,050 | $143.29 | $580,328.55 |
DisclosureSEC source: 0001179110-21-008454 · edgar.xml · nonDerivative · entry 1 Geshuri Arnnon · CIK 0001830520 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,908 F1 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. Read SEC document |
| May 26, 2021 Filed May 27, 2021 20:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 3,959 | $146.40 | $579,601.56 |
DisclosureSEC source: 0001179110-21-006004 · edgar.xml · nonDerivative · entry 1 Geshuri Arnnon · CIK 0001830520 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,958 F1 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. Read SEC document |
| March 16, 2021 Filed Mar 18, 2021 21:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 350 | $0.00 Strike: $2.73 | $0.00 |
DisclosureSEC source: 0001179110-21-003591 · edgar.xml · derivative · entry 3 Geshuri Arnnon · CIK 0001830520 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 235,278 Underlying: Common Stock · 350 shares Expires 2027-12-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on December 11, 2020. F2 · derivative.exercise_date: One-fourth of the option vested on December 4, 2018 and 1/48 of the option vests monthly thereafter. Read SEC document |
| March 16, 2021 Filed Mar 18, 2021 21:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 350 | $205.00 | $71,750.00 |
DisclosureSEC source: 0001179110-21-003591 · edgar.xml · nonDerivative · entry 2 Geshuri Arnnon · CIK 0001830520 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,917 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on December 11, 2020. Read SEC document |
| March 16, 2021 Filed Mar 18, 2021 21:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 350 | $2.73 | $955.50 |
DisclosureSEC source: 0001179110-21-003591 · edgar.xml · nonDerivative · entry 1 Geshuri Arnnon · CIK 0001830520 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,267 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on December 11, 2020. Read SEC document |
| February 26, 2021 Filed Mar 1, 2021 21:22 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 3,902 | $222.26 | $867,266.32 |
DisclosureSEC source: 0001179110-21-002433 · edgar.xml · nonDerivative · entry 1 Geshuri Arnnon · CIK 0001830520 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,917 F1 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. Read SEC document |
| February 16, 2021 Filed Feb 17, 2021 22:26 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,750 | $0.00 Strike: $2.73 | $0.00 |
DisclosureSEC source: 0001179110-21-001828 · edgar.xml · derivative · entry 3 Geshuri Arnnon · CIK 0001830520 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 235,628 Underlying: Common Stock · 1,750 shares Expires 2027-12-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on December 14, 2020. F2 · derivative.exercise_date: One-fourth of the option vested on December 4, 2018 and 1/48 of the option vests monthly thereafter. Read SEC document |
| February 16, 2021 Filed Feb 17, 2021 22:26 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 1,750 | $298.26 | $521,955.00 |
DisclosureSEC source: 0001179110-21-001828 · edgar.xml · nonDerivative · entry 2 Geshuri Arnnon · CIK 0001830520 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,819 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on December 14, 2020. Read SEC document |
| February 16, 2021 Filed Feb 17, 2021 22:26 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,750 | $2.73 | $4,777.50 |
DisclosureSEC source: 0001179110-21-001828 · edgar.xml · nonDerivative · entry 1 Geshuri Arnnon · CIK 0001830520 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,569 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on December 14, 2020. Read SEC document |
| January 14, 2021 Filed Jan 19, 2021 21:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,750 | $0.00 Strike: $2.73 | $0.00 |
DisclosureSEC source: 0001179110-21-000670 · edgar.xml · derivative · entry 3 Geshuri Arnnon · CIK 0001830520 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 237,378 Underlying: Common Stock · 1,750 shares Expires 2027-12-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: One-fourth of the option vested on December 4, 2018 and 1/48 of the option vests monthly thereafter. Read SEC document |
| January 14, 2021 Filed Jan 19, 2021 21:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 1,750 | $226.66 | $396,655.00 |
DisclosureSEC source: 0001179110-21-000670 · edgar.xml · nonDerivative · entry 2 Geshuri Arnnon · CIK 0001830520 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,819 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on December 14, 2020. Read SEC document |
| January 14, 2021 Filed Jan 19, 2021 21:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,750 | $2.73 | $4,777.50 |
DisclosureSEC source: 0001179110-21-000670 · edgar.xml · nonDerivative · entry 1 Geshuri Arnnon · CIK 0001830520 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,569 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 27, 2020 Filed Nov 30, 2020 21:03 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 3,924 | $194.89 | $764,748.36 |
DisclosureSEC source: 0001179110-20-011459 · edgar.xml · nonDerivative · entry 1 Geshuri Arnnon · CIK 0001830520 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,819 F1 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. Read SEC document |
| November 03, 2020 Filed Nov 5, 2020 22:04 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantEmployee Stock Option (right to buy) · Derivative | 34,456 | Not disclosed Strike: $5.26 | Not disclosed |
DisclosureSEC source: 0001104659-20-121880 · a4.xml · derivative · entry 3 Geshuri Arnnon · CIK 0001830520 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,456 Underlying: Common Stock · 34,456 shares Expires 2028-06-18 F4 · derivative.exercise_price: Reflects options acquired by the Reporting Person on October 30, 2020, upon completion of the Merger pursuant to the Merger Agreement, based on the Reporting Person's previously outstanding options of Livongo, multiplied by an equity award adjustment ratio of 0.6891 (rounded down to the nearest whole share), which was only determinable on November 3, 2020 in accordance with the Merger Agreement. Upon completion of the Merger, the exercise prices of the Reporting Person's options were adjusted based on the quotient of the exercise price of the Reporting Person's previously outstanding options of Livongo over an equity award adjustment ratio of 0.6891 (rounded up to the nearest whole cent), which was only determinable on November 3, 2020 in accordance with the Merger Agreement. F4 · date: Reflects options acquired by the Reporting Person on October 30, 2020, upon completion of the Merger pursuant to the Merger Agreement, based on the Reporting Person's previously outstanding options of Livongo, multiplied by an equity award adjustment ratio of 0.6891 (rounded down to the nearest whole share), which was only determinable on November 3, 2020 in accordance with the Merger Agreement. Upon completion of the Merger, the exercise prices of the Reporting Person's options were adjusted based on the quotient of the exercise price of the Reporting Person's previously outstanding options of Livongo over an equity award adjustment ratio of 0.6891 (rounded up to the nearest whole cent), which was only determinable on November 3, 2020 in accordance with the Merger Agreement. F4 · price: Reflects options acquired by the Reporting Person on October 30, 2020, upon completion of the Merger pursuant to the Merger Agreement, based on the Reporting Person's previously outstanding options of Livongo, multiplied by an equity award adjustment ratio of 0.6891 (rounded down to the nearest whole share), which was only determinable on November 3, 2020 in accordance with the Merger Agreement. Upon completion of the Merger, the exercise prices of the Reporting Person's options were adjusted based on the quotient of the exercise price of the Reporting Person's previously outstanding options of Livongo over an equity award adjustment ratio of 0.6891 (rounded up to the nearest whole cent), which was only determinable on November 3, 2020 in accordance with the Merger Agreement. F6 · derivative.exercise_date: One-fourth of the option vested on June 19, 2019 and 1/48 of the option vests monthly thereafter. Read SEC document |
| November 03, 2020 Filed Nov 5, 2020 22:04 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantEmployee Stock Option (right to buy) · Derivative | 239,128 | Not disclosed Strike: $2.73 | Not disclosed |
DisclosureSEC source: 0001104659-20-121880 · a4.xml · derivative · entry 2 Geshuri Arnnon · CIK 0001830520 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 239,128 Underlying: Common Stock · 239,128 shares Expires 2027-12-03 F4 · derivative.exercise_price: Reflects options acquired by the Reporting Person on October 30, 2020, upon completion of the Merger pursuant to the Merger Agreement, based on the Reporting Person's previously outstanding options of Livongo, multiplied by an equity award adjustment ratio of 0.6891 (rounded down to the nearest whole share), which was only determinable on November 3, 2020 in accordance with the Merger Agreement. Upon completion of the Merger, the exercise prices of the Reporting Person's options were adjusted based on the quotient of the exercise price of the Reporting Person's previously outstanding options of Livongo over an equity award adjustment ratio of 0.6891 (rounded up to the nearest whole cent), which was only determinable on November 3, 2020 in accordance with the Merger Agreement. F4 · date: Reflects options acquired by the Reporting Person on October 30, 2020, upon completion of the Merger pursuant to the Merger Agreement, based on the Reporting Person's previously outstanding options of Livongo, multiplied by an equity award adjustment ratio of 0.6891 (rounded down to the nearest whole share), which was only determinable on November 3, 2020 in accordance with the Merger Agreement. Upon completion of the Merger, the exercise prices of the Reporting Person's options were adjusted based on the quotient of the exercise price of the Reporting Person's previously outstanding options of Livongo over an equity award adjustment ratio of 0.6891 (rounded up to the nearest whole cent), which was only determinable on November 3, 2020 in accordance with the Merger Agreement. F4 · price: Reflects options acquired by the Reporting Person on October 30, 2020, upon completion of the Merger pursuant to the Merger Agreement, based on the Reporting Person's previously outstanding options of Livongo, multiplied by an equity award adjustment ratio of 0.6891 (rounded down to the nearest whole share), which was only determinable on November 3, 2020 in accordance with the Merger Agreement. Upon completion of the Merger, the exercise prices of the Reporting Person's options were adjusted based on the quotient of the exercise price of the Reporting Person's previously outstanding options of Livongo over an equity award adjustment ratio of 0.6891 (rounded up to the nearest whole cent), which was only determinable on November 3, 2020 in accordance with the Merger Agreement. F5 · derivative.exercise_date: One-fourth of the option vested on December 4, 2018 and 1/48 of the option vests monthly thereafter. Read SEC document |
| November 03, 2020 Filed Nov 5, 2020 22:04 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantCommon Stock | 78,707 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-20-121880 · a4.xml · nonDerivative · entry 1 Geshuri Arnnon · CIK 0001830520 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,743 F1 · date: Reflects shares of common stock, par value $0.001 per share, of the Issuer ("Common Stock") underlying restricted stock units ("RSUs") acquired by the Reporting Person on October 30, 2020, upon completion of the merger (the "Merger") of Tempranillo Merger Sub, Inc., a wholly owned subsidiary of the Issuer, with and into Livongo Health, Inc. ("Livongo") pursuant to the Agreement and Plan of Merger, dated as of August 5, 2020 (the "Merger Agreement"), based on the Reporting Person's previously outstanding RSUs of Livongo multiplied by an equity award adjustment ratio of 0.6891 (rounded down to the nearest whole share), which was only determinable on November 3, 2020 in accordance with the Merger Agreement. F1 · shares: Reflects shares of common stock, par value $0.001 per share, of the Issuer ("Common Stock") underlying restricted stock units ("RSUs") acquired by the Reporting Person on October 30, 2020, upon completion of the merger (the "Merger") of Tempranillo Merger Sub, Inc., a wholly owned subsidiary of the Issuer, with and into Livongo Health, Inc. ("Livongo") pursuant to the Agreement and Plan of Merger, dated as of August 5, 2020 (the "Merger Agreement"), based on the Reporting Person's previously outstanding RSUs of Livongo multiplied by an equity award adjustment ratio of 0.6891 (rounded down to the nearest whole share), which was only determinable on November 3, 2020 in accordance with the Merger Agreement. F2 · shares: The shares of Common Stock underlying the RSUs vest as follows: (1) 41,273 RSUs vest in 48 equal monthly installments beginning on January 15, 2019, although the vesting of these RSUs beginning in February 2020 was modified by Livongo such that the RSUs vest on the February 25, May 25, August 25 or November 25 that occurs immediately prior to applicable vesting date, and (ii) 23,688 and 13,746 RSUs vest in 16 equal quarterly installments beginning on August 25, 2019, and May 25, 2020, respectively. F1 · price: Reflects shares of common stock, par value $0.001 per share, of the Issuer ("Common Stock") underlying restricted stock units ("RSUs") acquired by the Reporting Person on October 30, 2020, upon completion of the merger (the "Merger") of Tempranillo Merger Sub, Inc., a wholly owned subsidiary of the Issuer, with and into Livongo Health, Inc. ("Livongo") pursuant to the Agreement and Plan of Merger, dated as of August 5, 2020 (the "Merger Agreement"), based on the Reporting Person's previously outstanding RSUs of Livongo multiplied by an equity award adjustment ratio of 0.6891 (rounded down to the nearest whole share), which was only determinable on November 3, 2020 in accordance with the Merger Agreement. F3 · balance_after: Includes shares of Livongo common stock acquired under the Livongo Health, Inc. 2019 Employee Stock Purchase Plan that were converted into 125 shares of Common Stock pursuant to the Merger Agreement. Read SEC document |
| October 30, 2020 Filed Nov 3, 2020 21:13 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantCommon Stock | 25,911 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-20-120945 · a4.xml · nonDerivative · entry 1 Geshuri Arnnon · CIK 0001830520 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,911 F1 · shares: Reflects shares of common stock, par value $0.001 per share, of the Issuer ("Common Stock") acquired by the Reporting Person on October 30, 2020, upon completion of the merger (the "Merger") of Tempranillo Merger Sub, Inc., a wholly owned subsidiary of the Issuer, with and into Livongo Health, Inc. pursuant to the Agreement and Plan of Merger, dated as of August 5, 2020 (the "Merger Agreement"). Pursuant to the Merger Agreement, upon completion of the Merger, each issued and outstanding share of Livongo common stock was converted into the right to receive 0.5920 shares of Common Stock and $4.24 in cash, without interest. F1 · price: Reflects shares of common stock, par value $0.001 per share, of the Issuer ("Common Stock") acquired by the Reporting Person on October 30, 2020, upon completion of the merger (the "Merger") of Tempranillo Merger Sub, Inc., a wholly owned subsidiary of the Issuer, with and into Livongo Health, Inc. pursuant to the Agreement and Plan of Merger, dated as of August 5, 2020 (the "Merger Agreement"). Pursuant to the Merger Agreement, upon completion of the Merger, each issued and outstanding share of Livongo common stock was converted into the right to receive 0.5920 shares of Common Stock and $4.24 in cash, without interest. Read SEC document |
| October 30, 2020 Filed Nov 24, 2020 21:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 3,181 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-011315 · edgar.xml · derivative · entry 2 Geshuri Arnnon · CIK 0001830520 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,181 Underlying: Common Stock · 3,181 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F3 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning October 30, 2021. F3 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning October 30, 2021. Read SEC document |
| October 30, 2020 Filed Nov 24, 2020 21:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantEmployee Stock Option (right to buy) · Derivative | 7,365 | $0.00 Strike: $196.46 | $0.00 |
DisclosureSEC source: 0001179110-20-011315 · edgar.xml · derivative · entry 1 Geshuri Arnnon · CIK 0001830520 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,365 Underlying: Common Stock · 7,365 shares Expires 2030-10-30 F1 · derivative.exercise_date: The option vests as to 25% of the shares on October 30, 2021. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.